News

Melanoma pathogenesis in patient reveals phenotype-genotype paradox


 

References

A melanoma in a dysplastic nevus contained a phenotype-genotype disagreement confounding the exclusive significance of BRAF and NRAS mutations in melanoma pathogenesis, according to Dr. Jean-Marie Tan and associates.

A man in his 50s was diagnosed with a melanoma in a dysplastic nevus after being admitted with a irregularly pigmented melanocytic lesion. Microbiopsy specimens were taken across the lesion and genotyping was carried out on DNA samples for BRAF and NRAS mutations. The melanoma showed only BRAF wild-type, while the dysplastic nevus showed both BRAF wild-type and BRAF V600E mutations. Sequencing in all DNA samples revealed NRAS wild-type genotype, the researchers found.

These conflicting results indicate further studies are required to investigate the importance of other candidate genes linked to melanomagenesis, the investigators concluded.

Read the full article at JAMA Dermatology (doi:10.1001/jamadermatol.2014.3775).

Recommended Reading

New law will speed sunscreen ingredient approval
MDedge Hematology and Oncology
Ionizing radiation linked to BCC
MDedge Hematology and Oncology
Small victories add up to paradigm shifts for hard-to-treat tumors
MDedge Hematology and Oncology
FDA approves nivolumab for patients with advanced melanoma
MDedge Hematology and Oncology
RNA sequencing characterized high-risk squamous cell carcinomas
MDedge Hematology and Oncology
MEK inhibitors can induce skin eruptions with distinctive duskiness
MDedge Hematology and Oncology
Vitiligo indicates effective melanoma treatment, predicts survival benefit
MDedge Hematology and Oncology
Handheld device illuminates possible routes of melanoma metastases
MDedge Hematology and Oncology
Teledermoscopy referrals surpass paper for managing skin cancer patients
MDedge Hematology and Oncology
Xerosis is significant risk during targeted anticancer treatments
MDedge Hematology and Oncology